SMAD3 and type 2 diabetes mellitus: Liao et al. [17] reported that ADSCs transplantation inhibited liver fibrosis in type 2 diabetic rats by down-regulating TGF-β1 expression and Smad3 phosphorylation, suggesting that ADSCs can also be used to treat liver fibrosis.